Aura Biosciences, Inc. - Common Stock (AURA)

Historical Holders from Q4 2021 to Q3 2025

Symbol
AURA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
61,778,278
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51,649,515
Holdings value
$319,192,253
% of all portfolios
0%
Number of holders
105
Number of buys
48
Number of sells
-36
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aura Biosciences, Inc. - Common Stock (AURA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Matrix Capital Management Company, LP 11.17% $38,214,242 6,922,870 Matrix Capital Management Company LP 16 May 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.6% +25% $30,091,360 +$10,524,518 4,701,775 +53.8% Suvretta Capital Management, LLC 30 Jun 2025
BlackRock, Inc. 5.4% +10% $20,617,314 +$1,842,342 3,336,027 +9.8% BlackRock, Inc. 30 Sep 2025
Long Focus Capital Management, LLC 6.6% +75% $18,324,093 +$4,481,180 3,319,582 +32.4% LONG FOCUS CAPITAL MANAGEMENT, LLC 31 Mar 2025
Frazier Life Sciences Public Fund, L.P. 5% -49% $19,926,720 -$20,493,619 3,113,550 -50.7% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025

Institutional Holders of Aura Biosciences, Inc. - Common Stock (AURA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51,649,515 $319,192,253 +$6,254,101 $6.18 105
2025 Q2 50,616,053 $316,863,119 +$67,408,487 $6.26 102
2025 Q1 39,264,901 $230,096,030 -$11,860,142 $5.86 91
2024 Q4 39,449,434 $324,276,778 +$16,157,250 $8.22 93
2024 Q3 36,866,668 $329,191,609 -$25,783,402 $8.91 81
2024 Q2 39,765,227 $300,437,451 +$3,314,060 $7.56 75
2024 Q1 39,115,323 $307,072,789 +$16,222,241 $7.85 77
2023 Q4 36,998,812 $327,811,496 +$89,731,106 $8.86 71
2023 Q3 26,323,010 $236,119,190 -$5,574,466 $8.97 62
2023 Q2 27,066,492 $334,426,517 +$24,980,886 $12.35 59
2023 Q1 25,069,599 $232,645,346 +$10,922,124 $9.28 57
2022 Q4 23,806,818 $250,037,016 +$78,469,205 $10.5 49
2022 Q3 16,317,002 $295,663,462 +$9,714,465 $18.12 43
2022 Q2 15,793,428 $223,796,376 +$29,644,466 $14.17 42
2022 Q1 13,702,730 $298,756,000 +$9,092,301 $22 34
2021 Q4 13,081,587 $220,131,000 +$220,131,000 $16.98 32